Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1232.90
-12.60 (-1.01%)
< Home < Back

Dr. Reddy's Laboratories forays into hospital nutrition segment

Date: 25-08-2020

Dr. Reddy's Laboratories has forayed into hospital nutrition segment in the country with the launch of a new nutrition drink for people suffering with critical illnesses. It has 'Celevida Maxx' which is designed to help manage the nutritional needs of cancer, critical care and chronic obstructive poulmonary disease (COPD) patients.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.